Related Experiment Video
Updated: Jul 5, 2026
03:25
Simple Continuous Glucose Monitoring in Freely Moving Mice
Published on: February 24, 2023
Patient-level glucose reporting: averages, episodes, or something in between?
1University of North Carolina - Chapel Hill, Highgate, Durham, NC 27713, USA. sbraithw@med.unc.edu
Critical Care (London, England)
|April 22, 2008
Summary
The glycemic penalty index (GPI) accounts for both high and low blood glucose levels. This new index may improve how we manage insulin strategies and patient outcomes.
Area of Science:
- Critical care medicine
- Endocrinology
- Metabolic disorders
Background:
- The glycemic penalty index (GPI) is a novel metric that quantifies deviations from target blood glucose levels.
- It considers both hyperglycemia and hypoglycemia, weighting them based on their clinical significance.
- Existing metrics may not fully capture the impact of both high and low glucose episodes on patient outcomes.
Discussion:
- Severe hyperglycemic episodes have known adverse consequences, but overall hyperglycemia also impacts specific outcomes.
- While overall low blood glucose is linked to mortality, specific negative outcomes may stem from isolated hypoglycemic episodes.
- The GPI aims to integrate these disparate effects into a single, comprehensive measure.
Key Insights:
- The GPI provides a unified approach to assessing glycemic control, encompassing both hyperglycemic and hypoglycemic excursions.
- This index has the potential to refine our understanding of the relationship between glucose variability and clinical outcomes.
- By capturing the full spectrum of glucose deviations, the GPI may offer a more accurate assessment of glycemic risk.
Outlook:
- Further validation of the GPI is needed to establish its clinical utility.
- The GPI could potentially guide the development of more precise insulin dosing strategies.
- Its application may lead to improved patient outcomes by enabling better-defined glycemic targets in critical care settings.
Related Concept Videos
01:29Hyperglycemia
Hyperglycemia is an abnormally high blood glucose level. It is diagnosed by fasting glucose ≥126 mg/dL, 2-hour oral glucose tolerance test (or OGTT) ≥200 mg/dL, random glucose ≥200 mg/dL with symptoms, or HbA1c ≥6.5%. However, HbA1c results may be unreliable in certain conditions, such as anemia or hemoglobinopathies, and the diagnosis should be confirmed unless classic symptoms are present. Postprandial hyperglycemia is typically considered significant when glucose levels exceed 180 mg/dL two...
01:25Type II Diabetes Mellitus III: Clinical Manifestations and Diagnosis
Type 2 diabetes mellitus develops gradually and is often asymptomatic in early stages.Clinical ManifestationsWhen symptoms appear, they include fatigue, blurred vision, pruritus, delayed wound healing, and recurrent infections, particularly candidal infections. Peripheral neuropathy may present as numbness or tingling in the extremities. Classic hyperglycemia symptoms—polyuria, polydipsia, and polyphagia—are less common. Most patients are overweight and frequently have associated hypertension...
01:16Insulin: Dosing Regimen and Adverse Effects
Insulin-replacement therapy usually includes both long-acting insulin (basal) and short-acting insulin (to cater to postprandial needs). In a diverse group of type 1 diabetes patients, the average daily insulin dose is typically 0.5-0.7 units/kg body weight. However, obese patients and pubertal adolescents may need more due to insulin resistance.
The basal dose constitutes about 40%-50% of the total daily dose, with the rest as premeal insulin. The mealtime insulin dose should mirror...
The basal dose constitutes about 40%-50% of the total daily dose, with the rest as premeal insulin. The mealtime insulin dose should mirror...
01:14SBAR II: Application of SBAR
SBAR is an effective communication tool used by healthcare professionals to communicate patient information accurately. SBAR stands for Situation, Background, Assessment, and Recommendation. For a better understanding, an example is given below.
SBAR Report from a Nurse to a Health Care Provider
S: "Hello, Dr. Smith. This is Jane, RN, from the Med Surg unit. I am calling to tell you about Ms. White in Room 210, who is experiencing increased pain and redness at her incision site. Her recent...
SBAR Report from a Nurse to a Health Care Provider
S: "Hello, Dr. Smith. This is Jane, RN, from the Med Surg unit. I am calling to tell you about Ms. White in Room 210, who is experiencing increased pain and redness at her incision site. Her recent...
01:26Hypoglycemia
Hypoglycemia is a blood glucose level below 70 mg/dL. It commonly occurs in individuals using insulin or insulin-secreting drugs, but may also arise in non-diabetic conditions. People with type 1 diabetes are at the highest risk because they depend on exogenous insulin. People with type 2 diabetes are also at risk, especially when treated with insulin or medications such as sulfonylureas, which increase insulin release regardless of blood glucose levels. It develops when insulin levels exceed...
01:15Hypoglycemia and Glucagon
Without prolonged fasting, healthy individuals maintain blood glucose levels above 3.5 mM due to a well-adapted neuroendocrine counterregulatory system that effectively prevents acute hypoglycemia, a potentially life-threatening condition. The primary clinical scenarios for hypoglycemia encompass diabetes treatment, inappropriate production of endogenous insulin or insulin-like substances by tumors, and the use of glucose-lowering agents in non-diabetic individuals. Notably, hypoglycemia in the...